Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mallinckrodt plc

http://www.mallinckrodt.com

Latest From Mallinckrodt plc

Keeping Track: Genmab/AbbVie Epkinly, Krystal’s Vyjuvek Join US FDA’s 2023 Novel Approvals List

Oncology's surprisingly low numbers this year are among the latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.

US FDA Performance Tracker Approvals

Deal Watch: Vertex Calls On CRISPR Yet Again, Now To Collaborate On Type 1 Diabetes

Vertex and CRISPR look beyond beta thalassemia and sickle cell disease. Also, Bicycle gets $50m up front in Novartis deal, Regeneron commits $75m initially under a Treg collaboration with Sonoma, and Jounce gets a better deal from Concentra to wave off Redx merger.

Deals M & A

End Of US FDA’s Very Fast Reviews? 2022 Novel Approvals Stayed Close To PDUFA Timeframes

Moderation was a theme of the year in novel approvals, as CDER’s median review time rose for the first time in five years and even the center’s fastest approval took more than seven months. A Pink Sheet infographic breaks down which review pathways did the best last year. 

Pink Sheet Perspectives US FDA Performance Tracker

Will US FDA Advisory Committees Rebound In 2023?

The US FDA’s use of outside expert advisory committees rebounded from historic lows in 2022 – but just barely. Will Commissioner Califf’s ‘update’ of the process finally mean more committee meetings in 2023?

Pink Sheet Perspectives Advisory Committees
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
    • Generic Drugs
    • Specialty Pharmaceuticals
  • Other Names / Subsidiaries
    • Aspect Medical Systems, Inc.
    • BÂRRX Medical, Inc.
    • Cadence Pharmaceuticals, Inc.
    • CNS Therapeutics, Inc.
    • ev3 Inc.
    • Given Imaging Ltd.
    • Ikaria Holdings, Inc.
    • InfaCare Pharmaceutical Corporation
    • INO Therapeutics, LLC
    • Mallinckrodt Inc.
    • Mallinckrodt Pharmaceuticals
    • Micro Therapeutics, Inc.
    • Nellcor Puritan Bennett, Inc.
    • Ocera Therapeutics Inc. (OCRX)
    • Oridion Systems Ltd.
    • Questcor Pharmaceuticals, Inc.
    • Somanetics Corp.
    • Sonorant Inc.
    • SpecGx Inc.
    • Sucampo Pharmaceuticals, Inc.(SCMP)
    • VNUS Medical Technologies
    • Stratatech Corporation
    • Tranzyme Pharma
UsernamePublicRestriction

Register